Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing …
!["ANAVEX®3-71 Phase 2 Clinical Study"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/03/pexels-photo-3735718-1.webp?resize=600%2C400&ssl=1)
!["ANAVEX®3-71 Phase 2 Clinical Study"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/03/pexels-photo-3735718-1.webp?resize=600%2C400&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing …
BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies …